Cdc20 hypomorphic mice fail to counteract de novo synthesis of cyclin B1 in mitosis

Liviu Malureanu1, Karthik B Jeganathan, Fang Jin

  • 1Department of Pediatric and Adolescent Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

Insights

Cdc20 (anaphase-promoting complex activator) is essential for cell division, but its absence in mice doesn't cause cancer. New cyclin B1 synthesis delays cell cycle progression in Cdc20-deficient cells.

Area of Science:

  • Cell Biology
  • Genetics
  • Molecular Biology

Background:

  • Cdc20 is a key regulator of the anaphase-promoting complex/cyclosome (APC/C).
  • APC/C activation by Cdc20 triggers anaphase onset through cyclin B1 and securin degradation.
  • Understanding Cdc20's role is crucial for comprehending cell cycle control and potential disease implications.

Purpose of the Study:

  • To investigate the physiological importance of Cdc20 in higher eukaryotes.
  • To determine the consequences of reduced Cdc20 levels on organismal health and cancer predisposition.
  • To elucidate the mechanisms underlying cell cycle delays in Cdc20-deficient cells.

Main Methods:

  • Generation of hypomorphic mice with reduced Cdc20 expression.
  • Analysis of aneuploidy, chromatin bridging, and chromosome-microtubule attachment in these mice.
  • Investigation of cyclin B1 synthesis and degradation dynamics during mitosis using techniques like translation inhibition.

Main Results:

  • Hypomorphic mice exhibited significant aneuploidy but remained healthy and cancer-free.
  • Cdc20 deficiency led to chromatin bridging and chromosome misalignment, indicating a role in sister chromatid separation and attachment.
  • De novo synthesis of cyclin B1 during mitosis in Cdc20-hypomorphic cells caused its accumulation and significantly delayed anaphase onset.

Conclusions:

  • Cdc20 is essential for accurate chromosome segregation and timely anaphase onset.
  • Regulated de novo synthesis of cyclin B1 during mitosis is a critical factor that makes Cdc20 rate-limiting for its degradation.
  • Despite causing aneuploidy, Cdc20 deficiency does not inherently lead to cancer in mice, suggesting complex regulatory networks.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...